title: Evaluation of four Narcissus cultivars as potential sources for galanthamine production.
abstract: Galanthamine, an alkaloid present in the Amaryllidaceae is currently undergoing clinical trials for the treatment of Alzheimer's. Common daffodils, Narcissus spp., contain galanthamine and other alkaloids. Four commercial Narcissus cultivars were evaluated as potential sources of galanthamine. Planting depths, planting densities, bulb size or flower bud removal did not affect galanthamine content.
authors.forename: R M
authors.initials: RM
authors.lastname: Moraes-Cerdeira
authors.forename: C L
authors.initials: CL
authors.lastname: Burandt
authors.forename: J K
authors.initials: JK
authors.lastname: Bastos
authors.forename: D
authors.initials: D
authors.lastname: Nanayakkara
authors.forename: J
authors.initials: J
authors.lastname: Mikell
authors.forename: J
authors.initials: J
authors.lastname: Thurn
authors.forename: J D
authors.initials: JD
authors.lastname: McChesney
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy; D005702:Galantamine / Q000096:biosynthesis* / Q000302:isolation & purification / Q000627:therapeutic use; D006801:Humans; D018517:Plant Roots; D010946:Plants, Medicinal / Q000145:classification / Q000378:metabolism*
chemical_list: D005702:Galantamine